[Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
D000085:Acetates; D000328:Adult; D001831:Body Temperature / Q000187:drug effects; D002582:Cervix Mucus / Q000187:drug effects*; D002715:Chlormadinone Acetate / Q000494:pharmacology* / Q000627:therapeutic use; D003127:Colposcopy; D003267:Contraception; D003276:Contraceptives, Oral / Q000494:pharmacology* / Q000627:therapeutic use; D004412:Dysmenorrhea / Q000188:drug therapy; D004715:Endometriosis / Q000188:drug therapy; D004958:Estradiol / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008599:Menstruation Disturbances / Q000188:drug therapy; D008656:Mestranol / Q000494:pharmacology* / Q000627:therapeutic use; D011374:Progesterone / Q000494:pharmacology* / Q000627:therapeutic use; D014626:Vaginal Smears
D000085:Acetates; D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D011374:Progesterone; D004958:Estradiol; D008656:Mestranol
Klinische Erfahrungen mit dem Präparat ovosiston unter besonderer Berücksichtigung des Zervixfaktors und der Vaginalzytologie.